On October 6, 2022, President Joe Biden announced a retroactive pardon for simple possession of marijuana. He also announced that the federal government will review marijuana’s federal scheduling. His announcement suggests that the federal government may reschedule cannabis or even deschedule cannabis. Rescheduling cannabis is a bad idea, as I explain below. If the government
The Oregon marijuana industry is hurting, much like industry in California and other states. Among the many reasons (overproduction, market saturation) is that federal marijuana laws have not been reformed at all. For years marijuana entrepreneurs and their cheerleaders have repeated the refrain that federal reform of marijuana laws is just around the corner. These
What is the TCPA again? For years past, we regularly counseled our clients about the Telephone Consumer Protection Act (“TCPA”) because the cannabis industry, like many others, were being targeted for TCPA violations which were sometimes legitimate, sometimes not. For those who are still unfamiliar, the TCPA is a federal statute that was passed in
The struggles of failing marijuana businesses to wind down and pay creditors in an orderly fashion serve no one. Among the problems marijuana businesses face such as lack of access to banking and onerous taxation stemming from IRC 280E is the lack of access to bankruptcy proceedings. This post discusses a Michigan-based medical marijuana company
People in the cannabis industry know that marijuana is federally classified as a schedule I controlled substance. Schedule I means the drug has no recognized medical value, has a high potential for abuse, and cannot be safely administered even under a doctor’s supervision. Other schedule I drugs include heroin, methamphetamine, and several psychedelic substances including
I’m guilty of dunking on the Federal Trade Commission (FTC) in the past for not doing more to protect cannabis consumers, despite the current federal illegality of cannabis. That may be changing, at least with respect to CBD consumers. Before diving into this latest development, I should mention that historically, cannabis is treated differently from
The U.S. Constitution gives Congress certain enumerated powers (Article I, Section 8), with powers “not delegated to the [federal government] by the Constitution, nor prohibited by it to the states, are reserved to the states respectively, or to the people” (Tenth Amendment). While one of the enumerated powers is the regulation of interstate commerce, the
If you’re a cannabis lab, researcher, or scientist, the NIH is interested in hearing your thoughts! Last week, the National Institute of Health (NIH) posted a request for information (RFI)* regarding identifying the barriers to cannabis research. Through this RFI, the NIH aims to address the problems that researchers face in attempting to study cannabis.
Tobacco paraphernalia is in many cases indistinguishable from cannabis paraphernalia, especially when products are unconnected to specific consumers. If an item can be used in both lawful and unlawful ways, it seems illogical to classify it as drug paraphernalia, unless the item is connected to illegal activity. Yet the approach of the U.S. federal authorities
After a vote last week, the National Conference of State Legislators (NCSL) adopted a revised cannabis policy measure (the “Directive“) which supports federally descheduling cannabis, as well as cannabis banking reform. At this point, it’s abundantly clear that the states have moved beyond cannabis prohibition. The NCSL is a non-partisan organization that represents all state
